HomeTRML • NASDAQ
add
Tourmaline Bio Inc
Previous close
$15.68
Day range
$15.30 - $16.40
Year range
$9.18 - $48.31
Market cap
397.52M USD
Avg Volume
650.78K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 14.89M | 202.64% |
Net income | -12.90M | -162.24% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -14.88M | -202.73% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 202.95M | 2,357.63% |
Total assets | 210.30M | 2,211.44% |
Total liabilities | 5.25M | 208.09% |
Total equity | 205.04M | — |
Shares outstanding | 25.65M | — |
Price to book | 1.56 | — |
Return on assets | -25.20% | — |
Return on capital | -26.01% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -12.90M | -162.24% |
Cash from operations | -9.35M | -107.98% |
Cash from investing | 3.89M | 7,180.00% |
Cash from financing | 68.14M | — |
Net change in cash | 62.68M | 1,477.04% |
Free cash flow | -8.82M | — |
About
Founded
2021
Website
Employees
44